CARGO Therapeutics

CARGO Therapeutics is dedicated to engineering best-in-class CAR T-cell therapy, striving to overcome resistance to cancer treatment and improve accessibility, with the goal of providing potentially curative therapies to more patients. CARGO is committed to outsmarting cancer by developing a new generation of advanced chimeric antigen receptor (CAR) T-cell therapies. Located at 835 Industrial Rd, Suite 400, San Carlos, California 94070, US, CARGO Therapeutics is focused on developing innovative solutions to enhance cancer treatment outcomes and patient experiences.

CARGO Therapeutics is rapidly advancing novel CAR T-cell therapies, addressing critical challenges such as manufacturing constraints, supply chain issues, and reimbursement hurdles. By focusing on these key areas, CARGO aims to expand the reach of these potentially life-saving treatments to a broader patient population. CARGO Therapeutics' mission is to deliver more cures and improve the lives of individuals battling cancer.

CARGO Therapeutics continues to innovate and push the boundaries of cancer treatment. With a strong commitment to research and development, CARGO Therapeutics is poised to make a significant impact in the field of oncology. We invite the management of CARGO Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.